FDA grants Breakthrough Therapy Designation for Roche’s Hemlibra in haemophilia A without inhibitors Read more
Sandoz and Pear Therapeutics to develop and commercialize prescription digital therapeutics Read more
ProBioGen Signs Second Contract Development Agreement with Tizona Therapeutics for Immuno-Oncology Antibody Project Read more
Gustave Roussy and Protagen AG collaborate to improve the risk profiling of cancer patients undergoing immunotherapy Read more